输血诊断市场规模、份额和成长分析（按产品类型、检测类型、最终用户、技术和地区划分）—2026-2033年产业预测

全球输血诊断市场规模预计在 2024 年达到 51.8 亿美元，从 2025 年的 54.7 亿美元成长到 2033 年的 85.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.7%。

由于对安全输血方法的需求不断增长以及筛检技术的进步，全球输血诊断市场正经历强劲成长。外科手术、创伤病例和慢性疾病的增加，对准确可靠的诊断提出了更高的要求。各国政府和医疗机构不断加强捐血筛检和病原体检测，进一步推动了市场的扩张。自动化免疫血液分析仪的普及显着提高了检查室效率，最大限度地减少了人为错误。此外，核酸增幅检查(NAT) 等创新技术透过检测传染性病原体，增强了血液安全性。我们也见证了多层次分子检测、病原体减少系统和快速诊断试剂盒的出现，同时，数位化连接和资料管理系统正在改善血液学检查室的监测、报告和合规性。

全球输血诊断市场驱动因素

全球输血诊断市场的主要驱动因素之一是血液传播疾病的增加以及人们对安全输血实践意识的提高。由于爱滋病、乙型肝炎和丙型肝炎等感染疾病仍然是全球重要的健康问题，因此对先进诊断检测的需求日益增长，以确保血液製品的安全性和品质。此外，医疗机构对监管合规性和严格安全通讯协定的日益重视，也推动了创新血液筛检技术和诊断解决方案的应用，从而促进了市场成长。

全球输血诊断市场面临的限制因素

全球输血诊断市场面临的主要限制因素之一是先进诊断技术和设备的高成本。许多医疗机构，尤其是在发展中地区的医疗机构，预算限制了其投资尖端血液筛检和检测解决方案的能力。这种经济障碍会阻碍快速且准确诊断方法的普及，最终影响病人安全和输血服务的整体效率。此外，新型诊断产品获得监管部门核准的复杂性也会进一步阻碍市场准入，并抑制产业创新。

全球输血诊断市场趋势

全球输血诊断市场正呈现自动化和数位化连接日益增强的显着趋势。检查室正越来越多地采用全自动平台，以简化检体处理、检测和结果解读等工作流程，从而提高检测的一致性，并缩短国家血库和大型医院等高需求环境下的周转时间。同时，实验室资讯管理系统 (LIMS) 和云端分析工具等数位化工具的整合也日益普及，有助于提高医疗网路间的可追溯性、即时追踪和资料共用。这种数位化转型不仅加强了监管合规性，还提高了整体营运效率，从而推动了市场的持续成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境
• 管道分析

全球输血诊断市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 装置
• 试剂盒和试剂
• 软体和服务

全球输血诊断市场规模（按检测类型和复合年增长率划分）（2026-2033 年）

• 传染病筛检（TTIs）
• 血型鑑定/血型检测
• 相容性和交叉测试
• 核酸增幅检查（NAT）
• 其他输血诊断

全球输血诊断市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 血库和输血服务
• 医院/临床检查室
• 诊断检查室
• 研究所

全球输血诊断市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 血清学/免疫检测
• 分子诊断（PCR/NAT）
• 次世代定序/先进平台
• 自动化、高通量系统

全球输血诊断市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Grifols, SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd f
• Quotient Limited
• Abbott Laboratories
• Ortho Clinical Diagnostics
• BioMerieux SA
• Siemens Healthineers
• Immucor, Inc.
• Danaher Corporation
• BD（Becton, Dickinson & Company）
• DiaSorin SpA
• Thermo Fisher Scientific Inc.
• BAG Healthcare GmbH
• Merck KGaA
• Sysmex Corporation
• Danaher
• Beckman Coulter Inc.
• Novartis AG
• Fresenius Kabi AG
• Cepheid

结论与建议

Global Blood Transfusion Diagnostics Market size was valued at USD 5.18 Billion in 2024 and is poised to grow from USD 5.47 Billion in 2025 to USD 8.53 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).

The global blood transfusion diagnostics market is experiencing robust growth driven by the increasing demand for safe transfusion methods and advancements in screening technologies. A rise in surgical procedures, trauma cases, and chronic diseases necessitates accurate and reliable diagnostics. Ongoing efforts by governments and healthcare organizations aim to enhance donor screening and pathogen detection, further fueling market expansion. The shift towards automated immunohematology analyzers has significantly improved laboratory efficiency by minimizing human error. Additionally, innovative techniques like nucleic acid amplification testing (NAT) enhance blood safety by detecting infectious agents. The industry is also seeing the emergence of multiprime molecular assays, pathogen-reduction systems, and rapid diagnostic kits, while digital connectivity and data management systems improve monitoring, reporting, and compliance in blood testing laboratories.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Transfusion Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Transfusion Diagnostics Market Segments Analysis

Global Blood Transfusion Diagnostics Market is segmented by Product Type, Test Type, End-User, Technology and region. Based on Product Type, the market is segmented into Instruments, Kits & Reagents and Software & Services. Based on Test Type, the market is segmented into Infectious Disease Screening (TTIs), Blood Grouping & Typing, Compatibility & Cross-match Testing, Nucleic Acid Testing (NAT) and Other Transfusion Diagnostics. Based on End-User, the market is segmented into Blood Banks & Transfusion Services, Hospitals / Clinical Labs, Diagnostic Laboratories and Research Institutes. Based on Technology, the market is segmented into Serology / Immunoassay, Molecular Diagnostics (PCR/NAT), Next-Generation Sequencing / Advanced Platforms and Automation & High-Throughput Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Transfusion Diagnostics Market

One of the key market drivers for the global blood transfusion diagnostics market is the increasing prevalence of bloodborne diseases and the rising awareness of safe blood transfusion practices. As infections such as HIV, hepatitis B, and hepatitis C remain significant health concerns worldwide, there is a heightened demand for advanced diagnostic testing to ensure the safety and quality of blood products. This, coupled with the growing emphasis on regulatory compliance and stringent safety protocols in healthcare settings, propels the adoption of innovative blood screening technologies and diagnostic solutions, thereby driving market growth.

Restraints in the Global Blood Transfusion Diagnostics Market

One key market restraint for the global blood transfusion diagnostics market is the high cost associated with advanced diagnostic technologies and equipment. Many healthcare facilities, particularly in developing regions, face budget constraints that limit their ability to invest in cutting-edge blood screening and testing solutions. This financial barrier can impede the implementation of rapid and accurate diagnostic methods, ultimately affecting patient safety and the overall efficiency of blood transfusion services. Additionally, the complexity involved in obtaining regulatory approvals for new diagnostic products further complicates market entry and could stifle innovation within the industry.

Market Trends of the Global Blood Transfusion Diagnostics Market

The Global Blood Transfusion Diagnostics market is witnessing a significant trend towards heightened automation and enhanced digital connectivity. Laboratories are increasingly adopting fully automated platforms, which streamline workflows related to sample manipulation, testing, and result interpretation, thereby improving consistency and reducing turnaround times in high-demand settings like national blood banks and large hospitals. Concurrently, the integration of digital tools such as Laboratory Information Management Systems (LIMS) and cloud-based analytics is gaining momentum, facilitating superior traceability, live tracking, and data sharing across healthcare networks. This digital transformation not only bolsters regulatory compliance but also enhances overall operational efficiency, positioning the market for sustained growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Pipeline Analysis

Global Blood Transfusion Diagnostics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
• Kits & Reagents
• Software & Services

Global Blood Transfusion Diagnostics Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Infectious Disease Screening (TTIs)
• Blood Grouping & Typing
• Compatibility & Cross-match Testing
• Nucleic Acid Testing (NAT)
• Other Transfusion Diagnostics

Global Blood Transfusion Diagnostics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Blood Banks & Transfusion Services
• Hospitals / Clinical Labs
• Diagnostic Laboratories
• Research Institutes

Global Blood Transfusion Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Serology / Immunoassay
• Molecular Diagnostics (PCR/NAT)
• Next-Generation Sequencing / Advanced Platforms
• Automation & High-Throughput Systems

Global Blood Transfusion Diagnostics Market Size & CAGR (2026-2033)

• North America (Product Type, Test Type, End-User, Technology)
  • US
  • Canada
• Europe (Product Type, Test Type, End-User, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End-User, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End-User, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End-User, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd f
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson & Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations